P. Amarenco, J. Bogousslavsky, A. Callahan, L. Goldstein, M. Hennerici et al., Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack, N Engl J Med, vol.355, pp.549-559, 2006.

A. Arboix, L. García-eroles, J. Massons, M. Oliveres, and C. Targa, Acute Stroke in Very Old People: Clinical Features and Predictors of In-Hospital Mortality, Journal of the American Geriatrics Society, vol.30, issue.suppl 2, pp.36-41, 2000.
DOI : 10.1111/j.1532-5415.2000.tb03026.x

A. Arboix, M. Miguel, E. Ciscar, L. Garcia-eroles, J. Massons et al., Cardiovascular risk factors in patients aged 85 or older with ischemic stroke, Clinical Neurology and Neurosurgery, vol.108, issue.7, pp.638-643, 2006.
DOI : 10.1016/j.clineuro.2005.10.010

I. Aubin-auger, A. Mercier, L. Baumann, A. Lehr-drylewicz, P. Imbert et al., Introduction à la recherche qualitative, Exercer, vol.84, pp.142-145, 2008.

N. Aziz, J. Leonardi-bee, M. Phillips, J. Gladman, L. Legg et al., Rééducation thérapeutique pour les patients vivant chez eux plus d'un an après un accident vasculaire cérébral (AVC)

N. Beckett, R. Peters, A. Fletcher, J. Staessen, L. Liu et al., Treatment of Hypertension in Patients 80 Years of Age or Older, New England Journal of Medicine, vol.358, issue.18, pp.1887-1898, 2008.
DOI : 10.1056/NEJMoa0801369

R. Benson and R. Sacco, STROKE PREVENTION, Neurologic Clinics, vol.18, issue.2
DOI : 10.1016/S0733-8619(05)70194-8

R. Bernabei, F. Landi, G. Gambassi, A. Sgadari, G. Zuccala et al., Randomised trial of impact of model of integrated care and case management for older people living in the community, BMJ, vol.316, issue.7141, pp.1348-1351, 1998.
DOI : 10.1136/bmj.316.7141.1348

G. Borgès-da-silva and L. Recherche, Qualitative : un autre principe d'action et de communication, Revue Médicale de l'Assurance Maladie, 2001.

R. Brown, J. Whisnant, J. Sicks, O. Fallon, W. Wiebers et al., Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989, Stroke, vol.27, issue.11, pp.373-380, 1996.

J. Burn, M. Dennis, J. Bamford, P. Sandercock, D. Wade et al., Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project [published erratum appears in Stroke 1994 Sep;25(9):1887], Stroke, vol.25, issue.2, pp.333-337, 1994.
DOI : 10.1161/01.STR.25.2.333

C. Bushnell, D. Olson, and X. Zhao, Secondary preventive medication persistence and adherence 1 year after stroke, Neurology, vol.77, issue.12, pp.1182-1190, 2011.
DOI : 10.1212/WNL.0b013e31822f0423

M. Cabana, C. Rand, and N. Powe, Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement, Pediatric Research, vol.45, issue.4, Part 2 of 2, pp.1458-1465, 1999.
DOI : 10.1203/00006450-199904020-00719

J. Cadwallader, C. Dibao-dina, and J. Lebeau, Inertie thérapeutique dans l'hypertension artérielle, Exercer, vol.100, issue.15, pp.37-43, 2012.

A. Caputo, Etude de la qualité de vie des patients et de leurs aidants naturels, après un accident vasculaire cérébral hospitalisés en unité neuro

F. Colivicchi, A. Bassi, M. Santini, and C. Caltagirone, Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke, Stroke, vol.38, issue.10, pp.2652-2657, 2007.
DOI : 10.1161/STROKEAHA.107.487017

M. Coutinho, H. Gerstein, Y. Wang, and S. Yusuf, The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years, Diabetes Care, vol.22, issue.2, pp.233-240, 1999.
DOI : 10.2337/diacare.22.2.233

M. Cranney, E. Warren, S. Barton, K. Gardner, and T. Walley, Why do GPs not implement evidence-based guidelines? A descriptive study, Family Practice, vol.18, issue.4, pp.359-363, 2001.
DOI : 10.1093/fampra/18.4.359

J. Davy, F. Razcka, L. Beck, T. Cung, and N. Combes, Traitement médicamenteux de la fibrillation atriale, Archives des maladies du coeur et des vaisseaux, vol.4, pp.63-70, 2004.

D. Schryver, E. Van-gijn, J. Kappelle, L. Koudstaal, P. Algra et al., Non???adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke, Journal of Neurology, vol.26, issue.11, pp.1316-1321, 2005.
DOI : 10.1007/s00415-005-0858-0

D. Carlo, A. Lamassa, M. Pracucci, G. Basile, A. Trefoloni et al., Stroke in the Very Old : Clinical Presentation and Determinants of 3-Month Functional Outcome: A European Perspective, Stroke, vol.30, issue.11, pp.2313-2319, 1999.
DOI : 10.1161/01.STR.30.11.2313

G. Donnan, M. Fisher, M. Macleod, and S. Davis, Stroke, The Lancet, vol.371, issue.9624, pp.1612-1635, 2008.
DOI : 10.1016/S0140-6736(08)60694-7

URL : https://hal.archives-ouvertes.fr/hal-00626465

S. Eames, K. Mckenna, L. Worrall, and S. Read, The Suitability of Written Education Materials for Stroke Survivors and Their Carers, Topics in Stroke Rehabilitation, vol.30, issue.3, pp.70-83, 2003.
DOI : 10.1016/0738-3991(90)90074-U

S. T. Engelter, M. Reichhart, L. Sekoranja, D. Georgiadis, A. Baumann et al., Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis, Neurology, vol.65, issue.11, pp.1795-1798, 2005.
DOI : 10.1212/01.wnl.0000183702.04080.27

C. Foerch, K. Ghandehari, G. Xu, and S. Kaul, Exploring gender distribution in patients with acute stroke: A multi-national approach, J Res Med Sci, vol.18, pp.10-16, 2013.

V. Frykman, B. Beerman, L. Rydén, and M. Rosenqvist, Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications, European Heart Journal, vol.22, issue.20, pp.1954-1959, 2001.
DOI : 10.1053/euhj.2000.2300

D. Giugliano and K. Esposito, Clinical Inertia as a Clinical Safeguard, JAMA, vol.305, issue.15, pp.1591-1592, 2011.
DOI : 10.1001/jama.2011.490

L. Goldstein, R. Adams, M. Alberts, L. Appel, L. Brass et al., American Heart Association; American Stroke Association Stroke Council Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group, pp.873-923, 2006.

D. Graillot, V. Quipourt, B. Bouillet, J. Petit, and P. Manckoundia, Précision HbA1c chez sujets agés : Diabète de type 2 chez le sujet âgé : quelles spécificités ? La Revue de Médecine Interne, pp.575-579, 2012.
DOI : 10.1016/j.revmed.2012.06.001

T. Hafsteinsd-ttir, M. Vergunst, E. Lindeman, and M. Schuurmans, Educational needs of patients with a stroke and their caregivers: A systematic review of the literature, Patient Education and Counseling, vol.85, issue.1, pp.14-25, 2011.
DOI : 10.1016/j.pec.2010.07.046

H. Autorité and D. Santé, Développement de la prescription de thérapeutiques non médicamenteuses validées, 2011.

H. Autorité and D. Santé, Prévention vasculaire après infarctus cérébral ou AIT, 2009.

H. Autorité and D. Santé, Prise en Charge des Patients Adultes atteints d'Hypertension Artérielle Essentielle, 2005.

D. Hier, M. Foulkes, M. Swiontoniowski, R. Sacco, P. Gorelick et al., Stroke recurrence within 2 years after ischemic infarction, Stroke, vol.22, issue.2, pp.155-161, 1991.
DOI : 10.1161/01.STR.22.2.155

I. Idris, G. Thomson, and J. Sharma, Diabetes mellitus and stroke, International Journal of Clinical Practice, vol.55, issue.Suppl, pp.48-56, 2006.
DOI : 10.1111/j.1368-5031.2006.00682.x

P. Sandercock, J. Wardlaw, R. Lindley, M. Dennis, G. Cohen et al., The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, Lancet, vol.379, issue.40, pp.2352-2363, 2012.

D. Kim, G. Ford, C. Kidwell, S. Starkman, F. Vinuela et al., UCLA Intra-Arterial Thrombolysis Investigators. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years, AJNR Am J Neuroradiol, vol.28, pp.159-163, 2007.

H. Kulbertus and A. Scheen, L'etude clinique du mois. L'etude PROSPER, Rev Med Liege, vol.57, issue.42, pp.809-813, 2002.

M. Law, N. Wald, and A. Rudnicka, Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, BMJ, vol.326, issue.7404, p.1423, 2003.
DOI : 10.1136/bmj.326.7404.1423

H. Lummis, I. Sketris, G. Gubitz, M. Joffres, and G. Flowerdew, Medication Persistence Rates and Factors Associated with Persistence in Patients Following Stroke: A Cohort Study, BMC Neurology, vol.45, issue.6, p.25, 2008.
DOI : 10.1046/j.1365-2125.1998.00716.x

J. Mant, F. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice et al., Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007.
DOI : 10.1016/S0140-6736(07)61233-1

A. Mitnitski, J. Graham, A. Mogilner, and K. Rockwood, Frailty, fitness and late-life mortality in relation to chronological and biological age, BMC Geriatrics, vol.213, issue.1, pp.2-10, 2002.
DOI : 10.1006/jtbi.2001.2430

A. V. Mohan and L. S. Phillips, Clinical Inertia and Uncertainty in Medicine JAMA, pp.383-384, 2011.

C. Murray and A. Lopez, Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study, The Lancet, vol.349, issue.9063, pp.1436-1442, 1997.
DOI : 10.1016/S0140-6736(96)07495-8

K. Nishant, A. Niaz, R. Kennedy, and . Lees, Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive, BMJ, vol.341, issue.52, p.6046, 2010.

E. Okonofua, K. Simpson, A. Jesri, S. Rehman, V. Durkalski et al., Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals, Hypertension, vol.47, issue.3, pp.345-351, 2006.
DOI : 10.1161/01.HYP.0000200702.76436.4b

C. Perret-guillaume, P. Miget, C. Aubry, R. Gueguen, E. Steyer et al., Contr??le de??la??pression art??rielle par??le??traitement antihypertenseur chez??le??sujet ??g?? de??60??ans et??plus, La Revue de M??decine Interne, vol.27, issue.4, pp.285-290, 2006.
DOI : 10.1016/j.revmed.2006.01.004

L. Phillips, W. Branch, C. Cook, J. P. Doyle, J. El-kebbi et al., Clinical Inertia, Annals of Internal Medicine, vol.135, issue.9, pp.825-834, 2001.
DOI : 10.7326/0003-4819-135-9-200111060-00012

J. Redfern, C. Mckevitt, R. Dundas, A. Rudd, and C. Wolfe, Behavioral Risk Factor Prevalence and Lifestyle Change After Stroke : A Prospective Study, Stroke, vol.31, issue.8, pp.1877-1881, 2000.
DOI : 10.1161/01.STR.31.8.1877

J. Röther, M. Alberts, and E. Touzé, Risk factor profile and management of cerebrovascular patients in the REACH Registry, Cerebrovasc. Dis, vol.25, pp.366-374, 2008.

L. Rubenstein, K. Josephson, G. Wieland, P. English, J. Sayre et al., Effectiveness of a Geriatric Evaluation Unit, New England Journal of Medicine, vol.311, issue.26, pp.1664-1670, 1984.
DOI : 10.1056/NEJM198412273112604

L. Rubenstein, D. Wieland, P. English, K. Josephson, J. Sayre et al., The Sepulveda VA Geriatric Evaluation Unit: Data on Four-year Outcomes and Predictors of Improved Patient Outcomes, Journal of the American Geriatrics Society, vol.28, issue.7, pp.503-512, 1984.
DOI : 10.1111/j.1532-5415.1984.tb02235.x

R. Sacco, P. Wolf, W. Kannel, and P. Mcnamara, Survival and recurrence following stroke. The Framingham study, Stroke, vol.13, issue.3, pp.290-295, 1982.
DOI : 10.1161/01.STR.13.3.290

G. Samsa, J. Bian, J. Lipscomb, and D. Matchar, Epidemiology of Recurrent Cerebral Infarction : A Medicare Claims??Based Comparison of First and Recurrent Strokes on 2-Year Survival and Cost, Stroke, vol.30, issue.2, pp.338-349, 1999.
DOI : 10.1161/01.STR.30.2.338

J. Schlienger, S. Vinzio, A. Pradignac, F. Grunenberger, and B. Goichot, Statines et risque c??r??bro- et cardiovasculaire chez les personnes ??g??es, La Revue de M??decine Interne, vol.25, issue.11, pp.801-805, 2004.
DOI : 10.1016/j.revmed.2004.01.013

J. Sharma, S. Fletcher, and M. Vassallo, Strokes in the Elderly ??? Higher Acute and 3-Month Mortality ??? An Explanation, Cerebrovascular Diseases, vol.9, issue.1, pp.2-9, 1999.
DOI : 10.1159/000015889

S. E. Straus, S. R. Majumdar, and F. A. Mcalister, New Evidence for Stroke Prevention, JAMA, vol.288, issue.11, pp.1388-1395, 2002.
DOI : 10.1001/jama.288.11.1388

A. Stuck, M. Egger, A. Hammer, C. Minder, and J. Beck, Home Visits to Prevent Nursing Home Admission and Functional Decline in Elderly People, JAMA, vol.287, issue.8, pp.1022-1028, 2002.
DOI : 10.1001/jama.287.8.1022

E. Touzé, J. Coste, M. Voicu, J. Kansao, R. Masmoudi et al., Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study, Stroke, vol.39, issue.6, pp.1834-1843, 2008.
DOI : 10.1161/STROKEAHA.107.503094

C. Van-rossum, H. Van-de-mheen, J. Witteman, A. Hofman, J. Mackenbach et al., Prevalence, Treatment, and Control of Hypertension by Sociodemographic Factors Among the Dutch Elderly, Hypertension, vol.35, issue.3, pp.814-821, 2000.
DOI : 10.1161/01.HYP.35.3.814

S. Vernino, R. Brown, and J. Sejvar, Cause-Specific Mortality After First Cerebral Infarction: A Population-Based Study, Stroke, vol.34, issue.8, pp.1828-1832, 2003.
DOI : 10.1161/01.STR.0000080534.98416.A0

B. Wettermark, A. Persson, and M. Von-euler, Secondary Prevention in a Large Stroke Population: A Study of Patients' Purchase of Recommended Drugs, Stroke, vol.39, issue.10, pp.2880-2885, 2008.
DOI : 10.1161/STROKEAHA.107.513390

P. Wolf, R. Abbott, and W. Kannel, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, vol.22, issue.8, pp.983-988, 1991.
DOI : 10.1161/01.STR.22.8.983

P. Wolf, R. Abbott, and W. Kannel, Atrial Fibrillation: A Major Contributor to Stroke in the Elderly, Archives of Internal Medicine, vol.147, issue.9, pp.1561-1564, 1987.
DOI : 10.1001/archinte.1987.00370090041008

C. Wu, H. Wu, J. Lee, and H. Weng, Stroke risk factors and subtypes in different age groups: A hospital-based study, Neurol India, vol.58, pp.863-868, 2010.

. Modérateur, Quelles difficultés rencontrez vous dans la prise en charge de la dyslipidémie chez le sujet âgé ayant présenté un AIC

. Modérateur, Quel est le pourcentage de patients âgés que vous suivez pour A C ischémique

. Médecin, C'est quand même plus fréquent chez les sujets très âgés, puis pour la moitie c'est sur des ACFA. Après les AIT sont quand même plus fréquents, 2 AIT pour 1 AVC. Les lourds on les a en tête alors que les AIT, bon, on n'y pense plus

. Modérateur, Quel est votre place dans le suivi de ces patients? Et il y a t'il d'autres médecins spécialistes dans ce suivi

. Modérateur, Quelles sont vos relations avec ces médecins spécialistes ? Quelles sont les difficultés rencontrées dans l'échange d'informations ou la discussion de la prise en charge

. Modérateur, Quelles sont les difficultés que vous rencontrez dans le suivi de ces patients

. Modérateur, Rencontrez vous des difficultés dans l'application des recommandations de l'HAS sur la prévention secondaire de l'A C de 2008? Lesquelles? Avez vous d'autres sources d'information

. Modérateur, Pensez vous avoir un rôle de prévention? Quels conseils donnez vous à ces patients

. Médecin, Puis les patients âgés peuvent être assez fatalistes, ils pensent qu'il y a rien à faire

. Modérateur, Quelles difficultés rencontrez vous dans la prise en charge de la dyslipidémie chez le sujet âgé ayant présenté un AIC